MBL2 and neoplasm: However, in the light of our preliminary findings a characterization of MBL levels as well as of other complement factors in patients’ serum could be an appealing project aiming at testing the specificity and sensitivity of these molecules in the PDAC setting but also at stratifying patients according to their tumor prognosis.